These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20100527)

  • 1. Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein.
    Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM
    J Biotechnol; 2010 Mar; 146(1-2):84-91. PubMed ID: 20100527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic TNFα-inhibitors that cross the human blood-brain barrier.
    Pardridge WM
    Bioeng Bugs; 2010; 1(4):231-4. PubMed ID: 21327054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
    Pardridge WM; Boado RJ
    Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horse.
    Boado RJ; Hui EK; Lu JZ; Pardridge WM
    J Pharmacol Exp Ther; 2010 Jun; 333(3):961-9. PubMed ID: 20233799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor.
    Boado RJ; Lu JZ; Hui EK; Sumbria RK; Pardridge WM
    Biotechnol Bioeng; 2013 May; 110(5):1456-65. PubMed ID: 23192358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG-single chain Fv fusion protein therapeutic for Alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkey.
    Boado RJ; Lu JZ; Hui EK; Pardridge WM
    Biotechnol Bioeng; 2010 Feb; 105(3):627-35. PubMed ID: 19816967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor receptor-IgG fusion protein for targeted drug delivery across the human blood-brain barrier.
    Hui EK; Boado RJ; Pardridge WM
    Mol Pharm; 2009; 6(5):1536-43. PubMed ID: 19624167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-penetrating tumor necrosis factor decoy receptor in the mouse.
    Zhou QH; Boado RJ; Hui EK; Lu JZ; Pardridge WM
    Drug Metab Dispos; 2011 Jan; 39(1):71-6. PubMed ID: 20884844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier molecular trojan horse enables imaging of brain uptake of radioiodinated recombinant protein in the rhesus monkey.
    Boado RJ; Hui EK; Lu JZ; Sumbria RK; Pardridge WM
    Bioconjug Chem; 2013 Oct; 24(10):1741-9. PubMed ID: 24059813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG-paraoxonase-1 fusion protein for targeted drug delivery across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Wang Y; Pardridge WM
    Mol Pharm; 2008; 5(6):1037-43. PubMed ID: 19434854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin receptor antibody-sulfamidase fusion protein penetrates the primate blood-brain barrier and reduces glycosoaminoglycans in Sanfilippo type A cells.
    Boado RJ; Lu JZ; Hui EK; Pardridge WM
    Mol Pharm; 2014 Aug; 11(8):2928-34. PubMed ID: 24949884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor.
    Coloma MJ; Lee HJ; Kurihara A; Landaw EM; Boado RJ; Morrison SL; Pardridge WM
    Pharm Res; 2000 Mar; 17(3):266-74. PubMed ID: 10801214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression in CHO cells and pharmacokinetics and brain uptake in the Rhesus monkey of an IgG-iduronate-2-sulfatase fusion protein.
    Lu JZ; Boado RJ; Hui EK; Zhou QH; Pardridge WM
    Biotechnol Bioeng; 2011 Aug; 108(8):1954-64. PubMed ID: 21351076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective plasma pharmacokinetics and brain uptake in the mouse of enzyme fusion proteins derived from species-specific receptor-targeted antibodies.
    Zhou QH; Boado RJ; Pardridge WM
    J Drug Target; 2012 Sep; 20(8):715-9. PubMed ID: 22845843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain protection from stroke with intravenous TNFα decoy receptor-Trojan horse fusion protein.
    Sumbria RK; Boado RJ; Pardridge WM
    J Cereb Blood Flow Metab; 2012 Oct; 32(10):1933-8. PubMed ID: 22714051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin receptor antibody-iduronate 2-sulfatase fusion protein: pharmacokinetics, anti-drug antibody, and safety pharmacology in Rhesus monkeys.
    Boado RJ; Ka-Wai Hui E; Zhiqiang Lu J; Pardridge WM
    Biotechnol Bioeng; 2014 Nov; 111(11):2317-25. PubMed ID: 24889100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Aug; 97(6):1376-86. PubMed ID: 17286273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts.
    Boado RJ; Lu JZ; Hui EK; Lin H; Pardridge WM
    Mol Pharm; 2016 Apr; 13(4):1385-92. PubMed ID: 26910785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Pardridge WM
    Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology.
    Pardridge WM
    BioDrugs; 2017 Dec; 31(6):503-519. PubMed ID: 29067674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.